Stewart Cheifet, the television producer and host who documented the personal computer revolution for nearly two decades on ...

Researchers at Google have used their Willow quantum computer to demonstrate that "quantum contextuality" may be a crucial ...

And, as we changed this means of interaction rather quickly, one way we did it has to do with games. Game engines are now AI ...

AI companies such as OpenAI and Anthropic have long focused on building tools that can write code that will speed up software ...

The simulation hypothesis—the idea that our universe might be an artificial construct running on some advanced alien computer ...

How can you take a holistic look at computing, from the top down? Computer science is the answer. As the trend toward globalization connects people in every part of the world, digital networks and ...

Abstract: Complicated deformation problems are frequently encountered in medical image registration tasks. Although various advanced registration models have been proposed, accurate and efficient ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

Abstract: We introduce a new protocol designed to assist in the forensic investigation of malicious network-based activity, specifically addressing the stepping-stone scenario in which an attacker ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...